GlaxoSmithKline a avut in T4 costuri de 3,5 mld. $ legate de probleme juridice in SUA
Compania farmaceutica GlaxoSmithKline (GSK) a avut in trimestrul al patrulea al anului trecut costuri juridice de circa 3,5 miliarde de dolari, asociate unei investigatii din Statele Unite privind practicile de vanzare a unor produse, dar si proceselor legate de medicamentul pentru diabet Avandia, potrivit Mediafax.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2011/01/4d3543295fdcb.jpg)
Costurile dupa plata impozitelor vor fi de 2,8 miliarde de dolari, a anuntat luni compania.
GSK, cel mai mare producator de medicamente din Marea Britanie, a anuntat in septembrie ca nu va mai promova Avandia la nivel mondial, dupa ce autoritatile de reglementare au decis ca produsul trebuie retras de pe piata europeana, in timp vanzarile din Statele Unite vor fi limitate din cauza riscului producerii unor crize cardiace.
In trimestrul al doilea al anului 2010, Glaxo a inregistrat costuri de 2,4 miliarde de dolari din cauza proceselor legate de Avandia, pentru acoperirea acordurilor de inchidere a investigatiilor autoritatilor americane la o fosta unitate de productie a companiei din Cidra, Puerto Rico.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/themes/strawberry-daily-202207/assets/images/avatar.png){kind=avatar}
Alte articole
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/tronson-autostrada.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/01/Bolojan-Guvernul_romaniei-rectorii.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/10/orange-vodafone-1.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/Donald-Trump.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/01/ilie-bolojan-1.webp)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/01/Florin-Barbu.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/Echipa-LTSM.jpeg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/12/CCR.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/plantare-ONG.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/Garbe_Industrial.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/vreme-februarie.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/11/Bolojan-Ilie.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/investitii-romania.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/Politico-Volodimir-Zelenski.png)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/copii-cyberbullying.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/11/cultura.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2025/08/diana-buzoianu.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/02/Macron.jpg)
